SEARCH BY NAME

BROWSE

Browse Australian delisted companies

0-9A BC DE F GH IJ KL MN OP QR ST UV WX YZ

Browse terminated Australian managed funds

0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

VIRALYTICS LIMITED (VLA)

Delisted from ASX 21/06/2018

SHARE PRICES

Former (or subsequent) names

 FROMTO
VIRALYTICS LIMITED28/12/2006
PSIRON LIMITED17/08/200028/12/2006
MEDICAL INNOVATIONS LIMITED17/08/2000

Shareholder links

Our website ranking of VLA: rating 5
(5 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Link Market Services,Level 21, 10 Eagle Street Brisbane QLD 4000
Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

Address: c/- Company Matters Pty Limited Level 12, 680 George St Sydney NSW 2000
Tel:  +61 2 9988 4000 Fax: +61 2 8068 6038

Date first listed: 15/10/1986
Company Secretary: Georgina Diab
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Intellectual property and investment company operating in the health care industry. In addition to the companies it invests in, Psiron has a number of active projects at various stages of development - these include treatments for dermatological condition
delisted from the close of trading on Thursday 21 June 2018 pursuant to Listing rule 17.11.21/06/2018
we understand Merck Sharp & Dohme was successful with a cash offer of $1.75 per VLA share21/06/2018
The scheme of arrangement between its shareholders and Merck Sharp & Dohme was approved by shareholders on 28 May 2018, and by the Federal Court of Australia on 4 June 2018 was implemented today. Viralytics is now 100% owned by MSD.20/06/2018
The securities of Viralytics Limited will be suspended from quotation at the close of trading today, Tuesday, 5 June 2018 in accordance with Listing Rule 17.2, following lodgement with the Australian Securities and Investments Commission of the orders of the Federal Court of Australia approving the scheme of arrangement by which Merck Sharp & Dohme Pty Ltd will acquire all of the issued shares in the Company.05/06/2018
a General Meeting is to be held at 11:00am on Thursday, 6 March 2014, at offices of McCullough Robertson, Level 15, 55 Hunter St, Sydney04/02/2014
The suspension of trading in the securities of Viralytics Limited will be lifted immediately, following receipt of an announcement regarding a capital raising22/11/2012
The securities of Viralytics Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement in relation to the outcome of a capital raising. Security Code: VLA21/11/2012
we understand that on or about this date the company consolidated its shares 1 for 1010/08/2011
name changed from Psiron Limited28/12/2006

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNATURENUMBERPRICEAMOUNT
    01/12/2016Paul Hopper10,000$1.155$11,550
    21/11/2016Paul Hopper5,000$1.195$5,975
    15/11/2016Paul Hopper5,000$1.275$6,375
    06/05/2016Paul HopperOn market6,000$0.800$4,800
    02/12/2014Peter TurveyOn market77,274$0.320$24,728

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Malcolm McCollManaging Director, CEO14/11/2012
    Robert VickeryCFO21/05/2013
    Riad El-DadaDirector20/06/2018
    Paul DoddDirector20/06/2018

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Paul HopperExecutive Chairman, Independent Director04/09/200820/06/2018
    Leonard PostNon Exec Director21/11/201120/06/2018
    Peter TurveyNon Exec Director08/09/201420/06/2018
    Phillip AltmanNon Exec Director12/07/200708/09/2014
    Peter MolloyNon Exec Director29/09/200808/09/2014
    Bryan DulhuntyManaging Director, CEO10/04/200624/07/2012

    Date of first appointment, title may have changed.